AstraZeneca welcomes Pfizer climbdown in takeover fight

LONDON, May 26 (Reuters) - AstraZeneca welcomed Pfizer's decision to abandon an attempt to buy the British drugmaker, which AstraZeneca said would allow it to focus on its growth as a standalone business.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.